Found: 30
Select item for more details and to access through your institution.
Long-term complete remission in a patient with high-risk primary mediastinal B-cell lymphoma and iatrogenic symptomatic bradycardia after only two courses of DA-EPOCH-R followed by chemo-free treatment.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 11, p. 4759, doi. 10.1007/s00277-024-05994-4
- By:
- Publication type:
- Article
Patients with multiple myeloma infected with COVID-19 during autologous stem cell transplantation.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Post-exposure prophylaxis with sotrovimab for Omicron (B.1.1.529) SARS-CoV-2 variant during the aplastic phase of autologous stem cell transplantation.
- Published in:
- Infectious Agents & Cancer, 2022, v. 17, n. 1, p. 1, doi. 10.1186/s13027-022-00454-y
- By:
- Publication type:
- Article
Atypical COVID-19 dynamics in a patient with mantle cell lymphoma exposed to rituximab.
- Published in:
- Infectious Agents & Cancer, 2021, v. 16, n. 1, p. 1, doi. 10.1186/s13027-021-00376-1
- By:
- Publication type:
- Article
The classical Hodgkin's lymphoma microenvironment and its role in promoting tumour growth and immune escape.
- Published in:
- Journal of Pathology, 2010, v. 221, n. 3, p. 248, doi. 10.1002/path.2711
- By:
- Publication type:
- Article
Long‐term efficacy and safety of dose‐dense and dose‐intense ABVD without consolidation radiotherapy in patients with advanced Hodgkin lymphoma: A 15‐year follow‐up of the ABVD<sub>DD‐DI</sub> phase II study.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 4, p. 1383, doi. 10.1111/bjh.19646
- By:
- Publication type:
- Article
Circulating dendritic cells deficiencies as a new biomarker in classical Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2019, v. 184, n. 4, p. 594, doi. 10.1111/bjh.15676
- By:
- Publication type:
- Article
A phase II study of dose-dense and dose-intense ABVD ( ABVD<sub>DD-DI</sub>) without consolidation radiotherapy in patients with advanced Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2014, v. 166, n. 1, p. 118, doi. 10.1111/bjh.12862
- By:
- Publication type:
- Article
Potential clinical implications of CD4<sup>+</sup>CD26<sup>high</sup> T cells for nivolumab treated melanoma patients.
- Published in:
- Journal of Translational Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12967-023-04184-6
- By:
- Publication type:
- Article
Body mass index is not associated with survival outcomes and immune-related adverse events in patients with Hodgkin lymphoma treated with the immune checkpoint inhibitor nivolumab.
- Published in:
- 2021
- By:
- Publication type:
- journal article
90-yttrium-ibritumomab tiuxetan as first-line treatment for follicular lymphoma: updated efficacy and safety results at an extended median follow-up of 9.6 years.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Impact of cemiplimab treatment duration on clinical outcomes in advanced cutaneous squamous cell carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 8, p. 1, doi. 10.1007/s00262-024-03728-z
- By:
- Publication type:
- Article
The subtle interplay between gamma delta T lymphocytes and dendritic cells: is there a role for a therapeutic cancer vaccine in the era of combinatorial strategies?
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 7, p. 1797, doi. 10.1007/s00262-020-02805-3
- By:
- Publication type:
- Article
Anti-PD1 Consolidation in Patients with Hodgkin Lymphoma at High Risk of Relapse after Autologous Stem Cell Transplantation: A Multicenter Real-Life Study.
- Published in:
- Cancers, 2022, v. 14, n. 23, p. 5846, doi. 10.3390/cancers14235846
- By:
- Publication type:
- Article
Response and Toxicity to Cytarabine Therapy in Leukemia and Lymphoma: From Dose Puzzle to Pharmacogenomic Biomarkers.
- Published in:
- Cancers, 2021, v. 13, n. 5, p. 966, doi. 10.3390/cancers13050966
- By:
- Publication type:
- Article
Efficacy and safety of the third-generation chloroethylnitrosourea fotemustine for the treatment of chemorefractory T-cell lymphomas.
- Published in:
- European Journal of Haematology, 2011, v. 87, n. 6, p. 547, doi. 10.1111/j.1600-0609.2011.01683.x
- By:
- Publication type:
- Article
Childhood Therapy-Related Acute Myeloid Leukemia with t(16;21)(q24;q22)/RUNX1-CBFA2T3 After a Primitive Neuroectodermal Tumor of the Chest Wall.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Overview of Targeted Drugs for Mature B-Cell Non-hodgkin Lymphomas.
- Published in:
- Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00443
- By:
- Publication type:
- Article
Functional coexpression of Interleukin (IL)-7 and its receptor (IL-7R) on Hodgkin and Reed-Sternberg cells: Involvement of IL-7 in tumor cell growth and microenvironmental interactions of Hodgkin's lymphoma.
- Published in:
- International Journal of Cancer, 2009, v. 125, n. 5, p. 1092, doi. 10.1002/ijc.24389
- By:
- Publication type:
- Article
Role of the EGFR ligand/receptor system in the secretion of angiogenic factors in mesenchymal stem cells.
- Published in:
- Journal of Cellular Physiology, 2011, v. 226, n. 8, p. 2131, doi. 10.1002/jcp.22548
- By:
- Publication type:
- Article
Tumor flare reactions and response to lenalidomide in patients with refractory classic Hodgkin lymphoma.
- Published in:
- American Journal of Hematology, 2010, v. 85, n. 1, p. 87, doi. 10.1002/ajh.21571
- By:
- Publication type:
- Article
Prognostic significance of combined analysis of ZAP-70 and CD38 in chronic lymphocytic leukemia.
- Published in:
- American Journal of Hematology, 2007, v. 82, n. 9, p. 787, doi. 10.1002/ajh.20936
- By:
- Publication type:
- Article
Rituximab therapy for chronic lymphocytic leukemia‐associated autoimmune hemolytic anemia.
- Published in:
- American Journal of Hematology, 2006, v. 81, n. 8, p. 598, doi. 10.1002/ajh.20665
- By:
- Publication type:
- Article
Tumor flare reaction associated with lenalidomide treatment in patients with chronic lymphocytic leukemia predicts clinical response.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 6, p. 1738, doi. 10.1002/cncr.26380
- By:
- Publication type:
- Article
RD-CODOX-M/IVAC with rituximab and intrathecal liposomal cytarabine in adult Burkitt lymphoma and 'unclassifiable' highly aggressive B-cell lymphoma.
- Published in:
- British Journal of Haematology, 2012, v. 156, n. 2, p. 234, doi. 10.1111/j.1365-2141.2011.08947.x
- By:
- Publication type:
- Article
Biweekly rituximab, cyclophosphamide, vincristine, non-pegylated liposome-encapsulated doxorubicin and prednisone (R-COMP-14) in elderly patients with poor-risk diffuse large B-cell lymphoma and moderate to high 'life threat' impact cardiopathy.
- Published in:
- British Journal of Haematology, 2011, v. 154, n. 5, p. 579, doi. 10.1111/j.1365-2141.2011.08786.x
- By:
- Publication type:
- Article
Elevation of clonal serum free light chains in patients with HIV-negative primary effusion lymphoma (PEL) and PEL-like lymphoma.
- Published in:
- 2009
- By:
- Publication type:
- Letter
A Combined Proteomic and Transcriptomic Signature Is Predictive of Response to Anti-PD-1 Treatment: A Retrospective Study in Metastatic Melanoma Patients.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 17, p. 9345, doi. 10.3390/ijms25179345
- By:
- Publication type:
- Article
Enhancing Dendritic Cell Cancer Vaccination: The Synergy of Immune Checkpoint Inhibitors in Combined Therapies.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 14, p. 7509, doi. 10.3390/ijms25147509
- By:
- Publication type:
- Article
Breakthrough in Blastic Plasmacytoid Dendritic Cell Neoplasm Cancer Therapy Owing to Precision Targeting of CD123.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 3, p. 1454, doi. 10.3390/ijms25031454
- By:
- Publication type:
- Article